Oxford Nanopore raises £31.4m to ramp up 'disposable' DNA sequencer
This article was originally published in Scrip
Oxford Nanopore Technologies, a UK spin-out from the University of Oxford that has developed a portable, disposable gene sequencing device, has raised £31.4 million in venture financing, bringing the total raised since inception in 2005 to £105.4 million. The MinION device is the size of a USB memory stick and is expected to retail at less than $900 when launched later this year as planned.
You may also be interested in...
The UK's main reimbursement bodies made a series of decisions this week that were broadly favorable and largely focused on oncology medicines.
While troubled Valeant was divesting iNova to private equity investors, Novartis announced a pair of oncology-focused deals, out-licensing a brain cancer drug to Midatech and partnering with IBM Watson Health to optimize breast cancer treatment.
Astellas and Pfizer have amended the PROSPER trial protocol in a bid to position Xtandi ahead of Zytiga in the early stage prostate cancer market.